AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MYHEALTHCHECKED PLC

Board/Management Information Nov 10, 2025

7803_rns_2025-11-10_727df9db-0ced-435d-8397-1557c6ecb175.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8898G

MyHealthChecked PLC

10 November 2025

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

Completion of Disposal and Board Changes

MyHealthChecked PLC (AIM: MHC) announces, further to the notification of 4 November 2025, that the disposal of Concepta Diagnostics Limited ("Disposal") completed earlier today.

Following completion of the Disposal, the Board Changes detailed in the notification of 14 October 2025 ("Notification") have taken effect and the Company has become an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies.

As set out in the Notification dated 14 October 2025 the Company is also required to change its name as soon as reasonably practicable following Completion. A further notification will be made when this change has been implemented.

For further information contact:

MyHealthChecked PLC www.myhealthchecked.com
Adam Reynolds, Executive Chairman via Walbrook PR
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Russell Cook
Walbrook PR Ltd (Media & IR) Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FUREAEFEFSXSFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.